A developmental perspective on the controversy surrounding the use of SSRIs to treat pediatric depression.
Leckman
James F
JF
King
Robert A
RA
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000367:Age Factors; D001714:Bipolar Disorder / Q000139:chemically induced; D002490:Central Nervous System / Q000187:drug effects / Q000254:growth & development; D002648:Child; D002657:Child Development / Q000187:drug effects; D002675:Child, Preschool; D003866:Depressive Disorder / Q000188:drug therapy*; D004348:Drug Labeling; D006801:Humans; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration / Q000706:statistics & numerical data
D017367:Selective Serotonin Reuptake Inhibitors